Assenagon Asset Management’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-1,371,469
| Closed | -$31.7M | – | 1461 |
|
|
2023
Q1 | $31.7M | Buy |
1,371,469
+483,220
| +54% | +$11.2M | 0.11% | 147 |
|
|
2022
Q4 | $23.3M | Sell |
888,249
-543,145
| -38% | -$14.2M | 0.08% | 201 |
|
|
2022
Q3 | $28.1M | Buy |
1,431,394
+369,512
| +35% | +$7.26M | 0.11% | 170 |
|
|
2022
Q2 | $18.6M | Buy |
+1,061,882
| New | +$18.6M | 0.07% | 224 |
|
|
2020
Q2 | – | Sell |
-2,480
| Closed | -$34K | – | 1234 |
|
|
2020
Q1 | $34K | Sell |
2,480
-75,553
| -97% | -$1.04M | ﹤0.01% | 709 |
|
|
2019
Q4 | $460K | Sell |
78,033
-6,342
| -8% | -$37.4K | ﹤0.01% | 632 |
|
|
2019
Q3 | $447K | Sell |
84,375
-23,985
| -22% | -$127K | ﹤0.01% | 674 |
|
|
2019
Q2 | $834K | Sell |
108,360
-984
| -0.9% | -$7.57K | 0.01% | 718 |
|
|
2019
Q1 | $2.18M | Buy |
+109,344
| New | +$2.18M | 0.02% | 457 |
|